FUJIFILM Diosynth Biotechnologies的动态

The oral solid dose (OSD) market is constantly evolving, with new trends and challenges emerging as pharma companies strive to streamline production, enhance efficiency and provide more patient-centric solutions. In a recent interview at CPHI Milan 2024 with Pharmaceutical Technology? Europe, Dr. Uwe Hanenberg, Head of Product Implementation at Recipharm, discussed these evolving trends, highlighting: ? The rising demand for highly potent APIs ? An increasing focus on oral biologics ? A growing reliance on digital solutions. Read our latest insight and watch the interview to learn more about the future of OSD and how CDMOs are adapting to meet these challenges: https://lnkd.in/dVJYUjpZ

A big thank you to all the speakers, sponsors, and attendees for making Pharmaceutical Development Conference (#PDC2024) a memorable and successful event. Together, Aphex Pharma Solutions and the pharmaceutical industry in Australia are shaping the future of pharmaceuticals. We are already looking forward to next year’s event. See you all at PDC 2025!! #ClinicalTrials #PDC2024 #clinicaltrial #manufacturing #CMO #CDMO #PDC2024 #Sydney #pharmaceuticalindustry #biotech #biotechnology #advancedmanufacturing #regulatoryaffairs #regulatorycompliance

Highlights of Pharmaceutical Development Conference #PDC2024 held in Sydney on October 22nd. The conference united industry leaders, innovators, and researchers to share insights and promote collaboration. Discussions focused on recent advancements and challenges in pharmaceutical development, showcasing a commitment to advancing R&D in Australia. A big thank you to all the speakers, sponsors, and attendees for making this event successful and memorable. Together, Aphex Pharma Solutions and the pharmaceutical industry in Australia are shaping the future of pharmaceuticals. We are already looking forward to next year’s event. See you all at PDC 2025. #ClinicalTrials #PDC2024 #clinicaltrial #manufacturing #CMO #CDMO #PDC2024 #Sydney #pharmaceuticalindustry #biotech #biotechnology #advancedmanufacturing #regulatoryaffairs #regulatorycompliance

This week, TileDB announced it is the preferred scientific discovery database for 50% of the top 20 global pharmaceutical companies, empowering researchers to analyze gene patterns at unprecedented resolution and advance their understanding of disease mechanisms at the cellular level. Learn more about how TileDB is using multimodal, multiomic data to improve precision medicine below. #Database #Pharma #Research #Multiomic

Read Now: https://lnkd.in/gR5XTrKc Incorporating AI in pharmaceutical operations is essential for staying competitive. Abid Rahman, SVP of Innovation at EVERSANA, explains how AI is revolutionizing across pharma. Dive into his Q&A on Pharmaceutical Executive. #AI #PharmaTech #EVERSANA

Today we are featuring an innovative pharma company ‘to watch’ Zerion Pharma from our CPHI Disruptor Watchlist.?? ? This company is transforming the pharmaceutical landscape by re-formulating sub-optimal soluble drugs that are currently not reaching their therapeutic potential. ??? ? Zerion Pharma has created a unique technology called Dispersome? that improves the solubility and bioavailability of both new and existing drugs.?? ? Their CEO, Ole Wiborg, stated in our interview that: “We are a key innovator in our field and will contribute to significant improvements across all therapeutic areas by making it possible to bring completely new drugs to the market.”?? ? Read the full interview below:?? ? #Pharma #CPHI #Therapeutics #ZerionPharma #DisruptorWatchlist?

Coming soon... The Science Series - a poster presentation deep dive, where we showcase our cutting-edge research capabilities through a collection of scientific posters. At IFF Pharma Solutions, we are committed to pushing the boundaries of pharmaceutical innovation. Each month, our Science Series will dive into some of the biggest challenges facing the pharmaceutical industry, from continuous manufacturing to excipient selection. The goal? To share insights from industry experts that will help our customers succeed. Join us on this journey as we unlock pharmaceutical breakthroughs with our cutting-edge research. Stay tuned for our latest findings coming soon! Learn more about our portfolio at pharma.iff.com #Excipients #IFFPharma #ContinuousManufacturing #PharmaInnovation

Carl Baker, our Vice President Business Unit Drug Substance at CARBOGEN AMCIS, has been featured in the Winter 2024 edition of Innovations in Pharmaceutical Technology (IPT)! ?? In his article, “Powering Pharma Innovation: Building a Workforce for the Future” (pages 14–17), Carl shares valuable insights on key strategies for leadership and talent development in the competitive pharmaceutical CDMO sector. ?? Highlights include: - Fostering continuous learning to adapt and excel. - Tailoring training programs to support individual and team growth. - Promoting mentorship to inspire innovation and collaboration. These strategies reflect the forward-thinking culture we champion at CARBOGEN AMCIS. ???? ?? Read the full article here: https://lnkd.in/d5YczDym A big thank you to Innovations in Pharmaceutical Technology (IPT) for providing this platform to share our vision and engage with the pharmaceutical community. We’d love to hear your thoughts—let us know what resonates with you! ?? (Innovations in Pharmaceutical Technology, December 2024, pages 14-17. ? Samedan Ltd)

?? ?? ?? TileDB is powering top pharmaceutical companies, helping them make advances in drug discovery at a faster pace #tiledb #multiomics #singlecell #genomics

School of Pharmaceutical Sciences, LPU hosts a webinar by Dr. Porselvi A on "Global Opportunities in Pharma."Join us to embrace this webinar #lpu #lpuuniversity #lpupharmaceutical #thinkbig